[123I]-6-deoxy-6-iodo-D-glucose (6DIG): A potential tracer of glucose transport

Nuclear Medicine and Biology

Volumn 24, Issue 6, 1997, Pages 527-534

  Henry, Christelle ^a   Koumanov, Françoise ^a   Ghezzi, Catherine ^a   Morin, Christophe ^b   Mathieu, Jean Paul ^a   Vidal, Michel ^b   De Leiris, Joël ^a   Comet, Michel ^a   Fagret, Daniel ^a  

^a UNIV GRENOBLE ALPES   (France)

^b UNIVERSITÉ JOSEPH FOURIER   (France)

Author keywords

3 O methyl D glucose; Glucose transport; Iodinated analogues of glucose; Radiopharmaceuticals; SPECT

Indexed keywords

3 METHYLGLUCOSE; 6 DEOXY 6 IODOGLUCOSE I 123; CYTOCHALASIN B; GLUCOSE; GLUCOSE DERIVATIVE; GLUCOSE TRANSPORTER; INSULIN; TRACER; UNCLASSIFIED DRUG; 6 DEOXY 6 IODOGLUCOSE; 6-DEOXY-6-IODOGLUCOSE; DEOXYGLUCOSE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; RADIOACTIVE IODINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG SYNTHESIS; ERYTHROCYTE; FEMALE; GLUCOSE TRANSPORT; HEART MUSCLE CELL; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; ISOLATED HEART; MALE; MOUSE; NEWBORN; NONHUMAN; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE DISTRIBUTION; ANIMAL; CELL CULTURE; HEART MUSCLE; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL; WISTAR RAT;

ANIMALS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; DEOXYGLUCOSE; ERYTHROCYTES; FEMALE; GLUCOSE; HUMANS; IODINE RADIOISOTOPES; MALE; MICE; MYOCARDIUM; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 0030608881     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00037-1     Document Type: Article

References (43)

1. Barnett J. E. G., Holman G. D. and Munday K. A. (1973) Structural requirements for binding to the sugar-transport system of the human erythrocyte. Biochem. J. 131, 211-221.
2. Basketter D. A. and Widdas W. F. (1978) Asymmetry of the hexose transfer system in human erythrocytes. Comparison of the effects of cytochalasin B, phloretin and maltose as competitive inhibitors. J. Physiol. 278, 389-401.
3. Blondel B., Roijeu I. and Cheneval J. P. (1971) Heart cell in culture: A simple method for increasing the proportion of myoblasts. Experientia 27, 356-358.
4. Bonadonna R. C., Del Prato S., Saccomani M. P., Bonora E., Gulli G., Ferrannini E., Bier D., Cobelli C. and DeFronzo R.A. (1993) Transmembrane glucose transport in skeletal muscle of patients with non-Insulin-dependent diabetes. J. Clin. Invest. 92, 486-494.
5. 11C]3-O-methyl-D-glucose and Positron Emission Tomography. J. Cereb. Blood Flow Metab. 6, 230-239.
6. Classon B., Liu Z. and Samuelsson B. (1988) New halogenation reagent systems useful for the mild one-step conversion of alcohols into iodides and bromides. J. Org. Chem. 53, 6126-6130.
7. 14CH3-glucose in the rat. Biochim. Biophys. Acta. 22, 185-186.
8. Feinendegen L. E., Herzog H., Wieler H., Patton D. D. and Schmid A. (1986) Glucose transport and utilization in human brain: Model using carbon-11 methylglucose and positron emission tomography. J. Nucl. Med. 27, 1867-1877.
9. Fernandez J. G. M., Gadelle A. and Defaye J. (1994) Difructose anhydrides from fructo-oligosaccharides and their uses as buiding blocks for the preparation of amphiphiles, liquid crystals and polymers. Carbohydr. Res. 265, 249-269.
10. 18F-labeled 2-deoxy-2-fluoro-D-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: Tissue distribution and imaging studies in animals. J. Nucl. Med. 18, 990-996.
11. Garvey W. T. (1992) Glucose transport and NIDDM. Diabetes Care 15, 396-417.
12. Gatley S. J. (1995) Iodine-123-labeled glucose analogs: Prospects for a single-Photon-emitting analog of fluorine-18-labeled deoxyglucose. Nucl. Med. Biol. 22, 829-835.
13. Gjedde A. and Diemer N. H. (1983) Autoradiographic determination of regional brain glucose content. J. Cereb. Blood Flow Metab. 3, 303-310.
14. Gjedde A. Wienhard K., Heiss W.-D., Kloster G., Diemer N. H., Herholz K. and Pawlik G. (1985) Comparative regional analysis of 2-fluorodeoxyglucose and methylglucose uptake in brain of four stroke patients. With special reference to the regional estimation of the lumped constant. J. Cereb. Blood Flow Metab. 5, 163-178.
15. Graff J. C., Hanson D. J. and Hatanaka M. (1973) Differences in cytochalasin B inhibition of 3-O-methylglucose uptake between balb / 3T3 cells and murine sarcoma virus transformed clone. Int. J. Cancer 12, 602-612.
16. Harary I. and Farley B. (1963) In vitro studies on single beating rat heart cells. I. Growth and organisation. Exp. Cell. Res. 29, 451-465.
17. Hardegger E. and Montavon R. M. (1946) Uber die Herstellung von α-und β-Chinovose-tetraacetate aus Glucose. Helv. Chim. Acta. 29, 1199-1203.
18. Hawkins R. A., Hoh C., Dahlbom M., Choi Y., Glaspy J., Tse N., Slamon D., Chen B., Messa C., Maddahi J. and Phelps M. E. (1991) PET cancer evaluations with FDG. J. Nucl. Med. 32, 1555-1558.
19. Henry C., Koumanov F., Ghezzi C., Mathieu J. P., Hamant S., de Leiris J. and Comet M. (1995) Experimental models, protocols and reference values for evaluation of iodinated analogues of glucose. Nucl. Med. Biol. 22, 875-885.
20. Ishii T. (1986) Facile preparation of deoxyiodocellulose and its conversion into 5,6-cellulosene. Carbohydr. Res. 154, 63-70.
21. Jagust W. J., Seab J. P., Huesman R. H., Valk P. E., Mathis C. A., Reed B. R., Coxson P. G. and Budinger T. F. (1991) Diminished glucose transport in Alzheimer's disease: Dynamic PET studies. J. Cereb. Blood Flow Metab. 11, 323-330.
22. James D. E. (1995) The mammalian facilitative glucose transporter family. NIPS 10, 67-71.
23. Kahlenberg A. and Dolansky D. (1972) Structural requirements of D-glucose for its binding to isolated human erythrocyte membranes. Can. J. Biochem. 50, 638-643.
24. Kalaria R. N. and Harik S. I. (1989) Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease. J. Neurochem. 53, 1083-1088.
25. 11C]-methyl-D-glucose, a potential agent for regional cerebral glucose utilization studies: Synthesis, chromatography and tissue distribution in mice. J. Labelled Compd. Radiopharm. 18, 855-863.
26. Kochetkov N. K., Kudryashov L. I. and Usov A. I. (1960) Interaction between di-O-isopropylidene-α-D-glucose and the halogen complexes of triphenyl phosphite. Dokl. Acad. Nauk. SSSR 33, 1094-1097; Engl. Transl. 909-912.
27. LeFevre P. G. and Marshall J. A. (1959) The attachment of phloretin and analogues to human erythrocytes in connection with inhibition of sugar transport. J. Biol. Chem. 234, 3022-3026.
28. Levine M., Levine S. and Jones M. N. (1971) The effect of temperature on the competitive inhibition of sorbose transfer in human erythrocytes by glucose. Biochim. Biophys. Acta 225, 291-300.
29. Lin S. and Spudich J. A. (1974) Biochemical studies on the mode of action of cytochalasin B. Cytochalasin B binding to red cell membrane in relation to glucose transport. J. Biol. Chem. 249, 5778-5783.
30. Lowry O., Rosebrough N., Lewisfarr A. and Randall R. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275.
31. Mathieu J. P., Riche F., Coornaert S., Bardy A., Busquet G., Godart J., Comet M. and Vidal M. (1982) Marquage d'acides gras en position ω par les isotopes de l'iode. J. Biophys. Med. Nucl. 6, 233-237.
32. Morgan H. E., Henderson M. J., Regen D. M. and Park C. R. (1961) Regulation of glucose uptake in muscle. 1. The effects of insulin and anoxia on glucose transport and phosphorylation in the isolated, perfused heart of normal rats. J. Biol. Chem. 236, 262-268.
33. Pardridge W. M. (1994) Glucose transport and phosphorylation: Which is rate limiting for brain glucose utilisation? Ann. Neurol. 35, 511-512.
34. Schelbert H. R. and Buxton D. (1988) Insights into coronary artery disease gained from metabolic imaging. Circulation 78, 496-505.
35. Schering-Kalbhaum AG. Improvement relating to the manufacture of X-ray photographs of the urogenital system. Br. patent no 361-437.
36. Simpson I. A., Chundu K. R., Davies-Hill T., Honer W. G. and Davies P. (1994) Decreased concentration of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's Disease. Ann. Neurol. 35, 546-551.
37. Sols A. and Crane R. K. (1954) Substrate specificity of brain hexokinase. J. Biol. Chem. 210, 581-595.
38. 11C-methyl-D-glucose (CMG) and dynamic positron emission tomography (dPET). In: Höfer R, Bergman H, eds. Radioaktive Isotope in Klinik und Forschung. H. Egermann, Vienna: Gasteiner internationals Symposium; 15, 129-142.
39. 11C-methyl-D-glucose (CMG) and dynamic positron emission tomography (dPET). In: Höfer R, Bergman H, eds. Radioaktive Isotope in Klinik und Forschung. H. Egermann, Vienna: Gasteiner internationals Symposium; 15, 129-142.
40. 11C-methyl- D-glucose (CMG) and dynamic positron emission tomography (dPET). Eur. J. Nucl. Med. 11, 97-106.
41. Wassenaar W. and Tator C. H. (1976) Carbohydrates as potential diagnostic tracers for brain tumors. J. Neurosurg. 44, 668-676.
42. Wassenaar W., Tator C. H. and Batty H. P. (1975) Glucose analogs as potential diagnostic tracers for brain tumors. Cancer Res. 35, 785-790.
43. Zaninetti D., Greco-Perotto R., Assimacopoulos-Jeannet F. and Jeanrenaud B. (1988) Effects of insulin on glucose transport and glucose transporters in rat heart. Biochem. J. 250, 277-283.